Drugs for Parkinson's disease.
D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D010627:Phenethylamines; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine